- Patent Title: WT1 peptide cancer vaccine composition for mucosal administration
-
Application No.: US14166970Application Date: 2014-01-29
-
Publication No.: US10206985B2Publication Date: 2019-02-19
- Inventor: Daisuke Asari , Kyohei Matsushita , Arimichi Okazaki , Yoshiki Maeda , Katsuyuki Okubo , Mitsuhiko Hori , Haruo Sugiyama
- Applicant: NITTO DENKO CORPORATION , OSAKA UNIVERSITY
- Applicant Address: JP Osaka JP Osaka
- Assignee: NITTO DENKO CORPORATION,OSAKA UNIVERSITY
- Current Assignee: NITTO DENKO CORPORATION,OSAKA UNIVERSITY
- Current Assignee Address: JP Osaka JP Osaka
- Agency: Greenblum & Bernstein, P.L.C.
- Priority: JP2013-020904 20130205
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K9/00
Abstract:
The present invention provides a cancer vaccine composition for mucosal administration for inducing cellular immunity, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a cellular immunity induction promoter. The composition efficiently induces cellular immunity against a cancer in a subject.
Public/Granted literature
- US20140220059A1 WT1 PEPTIDE CANCER VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION Public/Granted day:2014-08-07
Information query
